It’s a good article. GnRH analogues as a class should not be being prescribed off label like this.
Note the 800 million plus dollar a year market for them - it costs about a billion dollars to bring a drug to market and then you only have a limited timespan to make your money back before it goes off patent (15 years from patenting it and that includes years spent on trials.) so this one is a money spinner.
UK doctors cannot receive perks like the ones mentioned by the way - legally these days a branded mug is about as much as is allowed. The regulatory situation in the USA is rather different, but even then what this article describes is quasi legal at best. Again, very worrying.
Very interesting to see this quote: “We are currently conducting a specific review of nervous system and psychiatric events in association with the use of GnRH agonists, [a class of drugs] including Lupron, in pediatric patients,” the FDA said in a statement.”
That means there has been a critical mass of adverse effects reported.
The problem with drugs like this is that they’re being touted as some kind of harmless pause button - take them for a bit and stop if you want. But that is NOT the reality. These drugs affect multiple systems - they’re an extremely blunt tool and have effects all over the body. There’s also no long term follow up that’s been done on them.
These drugs should only be prescribed for a very specific, very narrow set of conditions - that they’re being used off label in the UK is very worrying.
There are going to be a lot of damaged lives from this. And lawsuits. Very, very sad.